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Blood alkalosis, as indicated by an increased blood bicarbonate concentration and pH,
has been shown to be beneficial for exercise performance. Sodium bicarbonate, sodium
citrate, and sodium or calcium lactate, can all result in increased circulating bicarbonate
and have all independently been shown to improve exercise capacity and performance
under various circumstances. Although there is considerable evidence demonstrating
the efficacy of these supplements in several sports-specific situations, it is commonly
acknowledged that their efficacy is equivocal, due to contrasting evidence. Herein, we
discuss the physiological and environmental factors that may modify the effectiveness
of these supplements including, (i) absolute changes in circulating bicarbonate; (ii)
supplement timing, (iii) the exercise task performed, (iv) monocarboxylate transporter
(MCT) activity; (v) training status, and (vi) associated side-effects. The aim of this narrative
review is to highlight the factors which may modify the response to these supplements,
so that individuals can use this information to attempt to optimize supplementation and
allow the greatest possibility of an ergogenic effect.
Keywords: buffering agents, alkalosis, bicarbonate, citrate, lactate
INTRODUCTION
Substances capable of increasing extracellular buffering capacity to combat exercise induced
acidosis have been researched for almost a century. Sodium bicarbonate, sodium citrate, and
sodium/calcium lactate can all result in alkalosis, indicated by an increase in blood pH and
circulating bicarbonate, and all have independently been shown to improve exercise capacity and
performance under various circumstances (1). Despite considerable evidence demonstrating these
supplements to be effective in specific situations (2, 3), it is commonly acknowledged that their
efficacy is equivocal due to contrasting evidence. Contradictory results from different investigations
are commonly cited to highlight that the ergogenic effect from increased bicarbonate concentration
is highly variable and is due to a variability in the individual responses. However, this may
be oversimplifying the complex nature of individual responses (i.e., physiological and genetic
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differences), whilst also overlooking experimental differences
(loading and exercise protocols), sample populations (i.e.,
untrained; physically active; trained individuals), and design
flaws (e.g., exercise unlikely to be affected by increased buffering
capacity).
Recent developments in the way in which researchers analyze
and interpret data is moving away from group means and toward
more in-depth analysis of individuals responses (4). This is
because we now know that there are several contributing factors
that determine how individuals respond to supplementation,
including their genetic composition, training status, habitual
diet, and other circumstantial factors. Identification of any
modifying factors that may alter the individual response
to supplementation with extracellular buffering agents would
provide vital information to clinicians, coaches, and athletes
about the likelihood of gaining a positive or negative response.
This would aid them in making fully informed decisions and
optimize each individual’s personal supplementation protocol.
The aim of this review is to summarize the current evidence
on the potential modifying factors underlying the individual
response to supplementation with extracellular buffering agents.
THE ROLE OF PH IN SKELETAL MUSCLE
FATIGUE
The ability of skeletal muscle tissue to maintain energy
production and generate mechanical work is closely linked to
performance in a variety of sports. The high turnover rate of
skeletal muscle ATP that is seen during high-intensity exercise
increases hydrogen ion (H+) production, leading to muscle
acidosis that is associated with performance loss (5). This is
because an exercise-induced metabolic acidosis, characterized by
a higher H+ production rather than removal rate, can decrease
energy substrate generation via glycolytic pathways by reducing
the activity of key enzymes such as glycogen phosphorylase and
phosphofructokinase (6). The H+ also compete with calcium
ions for the troponin binding site, directly hindering the muscle’s
contraction capacity (7). Oxidative phosphorylation can also be
inhibited by acidosis (6) while resynthesis of phosphorylcreatine
may also be compromised at low pH (8). Thus, a myoplasmic
drop in pH drives an inability to produce the desired or required
power output with a subsequent loss of exercise performance (9),
although not all agree (10).
The body has several endogenous systems to control pH
homeostasis; this balance is maintained by intracellular and
extracellular buffers which can accept or release H+ to prevent
dramatic pH changes. In muscle, intracellular physicochemical
buffers such as organic and inorganic phosphates, bicarbonate
anions, and histidine containing dipeptides, are the primary
mediators of pH homeostasis. There is also an active and
passive transport of H+ out of the muscle into the blood
mediated by transport systems; during intense activity, H+
eﬄux is mainly mediated by the lactate-proton transporters,
namely monocarboxylate transporter 1 (MCT1) and 4 (MCT4)
(11). Thereafter, the H+ are buffered by the circulating anion
bicarbonate (HCO−3 ), which forms carbonic acid, a weak acid.
These endogenous buffering systems are well-regulated and
highly efficient under normal physiological conditions (12).
However, these systems can be quickly overwhelmed by the
accumulation of H+ during exercise, particularly when the
intensity is high. Thus, increasing the buffering contribution of
one or more of these systems is a feasible way to improve control
of systemic pH changes and maintain exercise performance.
EXTRACELLULAR BUFFERING AGENTS
Several buffering agents are employed as ergogenic supplements,
including sodium bicarbonate (SB), sodium citrate (SC),
sodium lactate (SL), and calcium lactate (CL); the independent
mechanisms through which they increase circulating bicarbonate
will not be discussed here (for review see Lancha Junior et
al. (1)). Nonetheless, all substances are ingested with the same
focus: to increase the extracellular concentration of bicarbonate,
increasing H+ eﬄux out of the working muscle, thereby
contributing to muscle acid-base balance during exercise, which
may lead to an improved performance.
The ability of increased circulating bicarbonate to improve
exercise capacity and performance has been extensively studied.
It is widely acknowledged that the most effective extracellular
buffer is SB, with numerous narrative reviews (13, 14) and meta-
analyses (2, 3, 15, 16) demonstrating its efficacy. Meta-analytic
data have suggested SC supplementation to be ineffective for
performance (2), while limited data on SL and CL mean that
no meta-analytical data on their efficacy currently exists. Despite
this, supplementation with SC, SL, and CL has been shown
to improve exercise capacity and performance on numerous
independent occasions. Contrasting results in study outcomes
following ingestion of these supplements is often cited as
evidence that the response to these buffering supplements
is variable. Such generalized statements do not consider the
numerous contributing and modifying factors that influence
the response to supplementation and do not allow any single
individual to identify whether they are likely to benefit from
supplementation or not. Thus, it is of importance to determine
the factors that may contribute to an individual’s response to
these supplements.
POTENTIAL INFLUENCING FACTORS ON
THE EFFICACY OF EXTRACELLULAR
BUFFERS TO IMPROVE EXERCISE
CAPACITY AND PERFORMANCE
Increases in Circulating Bicarbonate
To gain a competitive advantage from increased extracellular
buffering capacity, there needs to be an increase in circulating
bicarbonate following supplementation. Theoretically, any
increase in bicarbonate would lead to a corresponding increase
in buffering capacity; what the minimal increase necessary
is to elicit performance gains is currently unknown. Carr
et al. (17) have suggested that a +5 mmol·L−1 increase from
baseline levels is required to have a potential ergogenic benefit
in exercise performance, while a +6 mmol·L−1 increase leads
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to almost certain ergogenic benefits. Despite this, no study to
date has directly investigated the minimal increase necessary
for performance gains or linked individual increases to change
in performance. Saunders et al. (18) determined whether there
were any correlations between blood values (bicarbonate, pH,
base excess) and exercise capacity. Surprisingly, we did not show
any relationship between the magnitude of change in circulating
bicarbonate (or any other measure) and subsequent changes in
exercise capacity.
Jones et al. (19) showed that no individual’s maximal increases
in circulating bicarbonate with a 0.1 g·kg−1 BM dose reached
a +5 mmol·L−1 increase, which could explain why this dose
appears to be ineffective for exercise performance (20). A 0.2
g·kg−1 BM dose, however, was effective at reaching this threshold
in all individuals (19), although the mean increase 60min post-
ingestion was < +5 mmol·L−1. Nonetheless, it is possible that
60min post-ingestion could coincide with a sufficient increase
(i.e., > +5 mmol·L−1) in bicarbonate for some individuals.
This could partially explain why a 0.2 g·kg−1 dose appears
to be effective in some (20, 21), but not all (22–24), studies
when exercise was performed 1 h post-supplementation. The
time to reach this suggested minimal threshold varies between
individuals (19), meaning it is possible that a higher proportion
of individuals had not attained sufficient alkalosis in the studies
showing no effect than those showing an effect, contributing to
the group effects shown.
A 0.3 g·kg−1 BM dose of SB is the most commonly employed
in the literature and appears to stem from the work of
McNaughton who showed this to be most effective compared
to lower and higher doses (20). Mean increases in circulating
bicarbonate prior to exercise following a 0.3 g·kg−1 BM dose of
SB is approximately +5–6 mmol·L−1 (25–27), and thus should
be sufficient to improve exercise capacity and performance (19).
Indeed, numerous studies have shown exercise gains with SB
at this dose (28–38), though similarly, substantial data exist
showing no effect following supplementation (26, 27, 34, 39–43).
This may, in part, be explained by the absolute increases in blood
bicarbonate shown prior to exercise, which appears to differ
substantially between studies (Figure 1). Certainly, this visual
demonstrates the importance in mean increases in circulating
bicarbonate prior to subsequent exercise performance, although
it must be acknowledged that several further contributing factors
may account for this variation including exercise models not
limited by H+ accumulation, genotype, associated-side effects,
and individual variation in the response to supplementation.
Few studies have investigated the effect of repeated
supplementation in the same individuals using the same exercise
protocol. We previously showed that SB supplementation in
the same individual produced consistent blood bicarbonate
responses, but this only translated into a mean improvement in
one of the four sessions when SB was ingested (27). Interestingly,
only one individual improved on all four occasions and nine
others on at least one occasion, suggesting that subsequent
exercise performance is more variable than blood responses.
Nonetheless, although mean increases in circulating bicarbonate
were approximately +6 mmol·L−1 during each session,
not all individuals may have achieved a sufficient increase
in circulating bicarbonate on every occasion. Additionally,
inconsistencies may also be due to the training status of the
participants who were recreationally active; trained individuals
are likely to perform more consistently with lower variation
between tests and thus may be better able to consistently take
advantage of increased buffering capacity. Indeed, Carr et al.
(41) showed 2,000m rowing performance was reliable following
repeated acute (0.3 g·kg−1 BM) and chronic (0.5 g·kg−1·day−1
BM for 3 days) supplementation in well-trained rowers,
although performance was not improved. Trained cyclists and
triathletes did consistently improve their cycling tolerance when
administered SB on repeated occasions (35). Thus, it is possible
that a proportion of the inconsistency in the response to SB (and
potentially SC, CL, and SL) may be attributed to the training
status of the individual and it would be of interest to determine
the within-participant repeatability following supplementation
using trained individuals.
Like the 0.3 g·kg−1 BM dose of SB, the most commonly
employed dose of SC is 0.5 g·kg−1 BM and can be attributed to
the pioneering work of McNaughton (54). Significant increases
in bicarbonate were shown 90min following a dose as low as
0.1 g·kg−1 BM, but since circulating bicarbonate increased in
a linear fashion, and the greatest amount of work completed
during a 60-s maximal exercise test was following a 0.5 g·kg−1
BM dose, this was considered the most effective. And yet,
despite impressive increases in blood bicarbonate following SC
supplementation, numerous studies have shown no effect on
exercise capacity or performance (55–57). In fact, meta-analytic
data showed an unclear effect of SC on exercise, with pre-
exercise alkalosis associated with a small but unclear effect
on performance (2). Indeed, despite clear increases in blood
bicarbonate, several studies have shown no positive effect on
subsequent exercise capacity or performance theoretically limited
by acidosis (Figure 2). Aside from other confounding factors,
discussed herein that may have modified the ergogenic effect of
supplementation with SC, these increasesmay be counteracted by
some other physiological response which inhibits the ergogenic
effect of increased buffering capacity.
Increases in blood bicarbonate following ingestion of calcium
or sodium lactate appear less obvious. Several studies have shown
increases of the magnitude of ∼+3 mmol·L−1 (67, 68) while
further studies showed no increase in circulating bicarbonate
following acute (26) and chronic (69) supplementation, which
explains the lack of an ergogenic effect in these studies. The +3
mmol·L−1 increase shown by Morris et al. (68) was sufficient
to improve exercise tolerance by 17% during a cycling capacity
test. Similarly, Morris et al. (70) showed improved high-intensity
exercise capacity with mean bicarbonate increases of only +2.5
and +2.6 mmol·L−1 following supplementation of 120 and
300 mg·kg−1 BM of CL. Lactate supplementation improved
running performance by a modest 1.7% (71), although changes
in bicarbonate in this study cannot be determined since blood
was only sampled at a solitary timepoint immediately prior to
exercise. Low (150 mg·kg−1 BM) and high (300 mg·kg−1 BM)
doses of CL lead to only moderate increases of +2 mmol·L−1
of bicarbonate, with no subsequent effect on repeated-bout
high-intensity exercise (72). Certainly, the modest increases
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FIGURE 1 | Increases in blood bicarbonate from baseline following acute supplementation with sodium bicarbonate, in order of magnitude of change. Data points
indicate whether exercise performance was improved with supplementation (dark circles) or not (light circles). The dotted lines indicate the thresholds for the zone of a
potential ergogenic effect (+5 mmol·L−1) and the zone of an almost certain ergogenic effect (+6 mmol·L−1); taken from Carr et al. (2) and Jones et al. (19). *Denotes
data estimated from graphs using specialized software (18, 20, 21, 23, 26, 29, 30, 33, 38, 42–53).
FIGURE 2 | Increases in blood bicarbonate from baseline following acute supplementation with sodium citrate, in order of magnitude of change. Data points indicate
whether exercise performance was improved with supplementation (dark circles) or not (light circles). The dotted lines indicate the thresholds for the zone of a
potential ergogenic effect (+5 mmol·L−1) and the zone of an almost certain ergogenic effect (+6 mmol·L−1); taken from Carr et al. (2) and Jones et al. (19). *Denotes
data estimated from graphs using specialized software (24), (54–66).
in blood bicarbonate with lactate supplementation appear to
be the primary factor behind the lack of an ergogenic effect
shown in some, but not all, studies with lactate supplementation
(Figure 3). Certainly, the individual range of bicarbonate
increases could have contributed to this variability as, for
example, the range in increases with low and high doses of
calcium was between +0.4 and +6.7 mmol·L−1 and changes in
bicarbonate were positively associated with the improvements in
exercise capacity (70). More studies should relate the individual
increases in circulating bicarbonate to changes in performance to
provide insight into this relationship.
It is currently unclear what the minimal increase in circulating
bicarbonate necessary is to result in an improvement in exercise
performance. This has been suggested to be of the order of +5
mmol·L−1 (17), although studies have shown mean increases
as little as +2.5 mmol·L−1 are sufficient to improve exercise
tolerance (70), while +2 mmol·L−1 generally do not (72).
Further research should investigate the smallest worthwhile
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change in blood bicarbonate that can consistently lead to exercise
gains.
Ingestion Timing
Siegler et al. (25) showed that increases in circulating bicarbonate
and absolute concentration are similar at 60, 120, and 180min
post-ingestion of 0.3 g·kg−1 BM SB. Since performance during
their repeated sprint protocol was not different when performed
at these different post-ingestion timepoints, it could be assumed
that precise timing of supplementation is of little importance
to obtain performance gains. Nonetheless, recent interest has
focused on the peak changes in circulating bicarbonate, with
theory suggesting that maximal increases in blood bicarbonate
will lead to maximal performance benefits, or at least the
greatest chance of improvements. Most studies have employed a
standardized supplementation protocol at a uniform timepoint.
Although the data of Siegler et al. (25) showed that mean changes
in circulating bicarbonate did not differ between timepoints, it is
unlikely that all individuals performed exercise at a point which
coincided with peak alkalosis.
A recent spate of investigations reporting the time course
changes in blood markers following acute supplementation with
SB (19, 73, 74), SC (75), and lactate (26, 72) suggest that a
uniform supplementation timepoint is unlikely to be optimal
for all individuals. The overwhelming conclusion that can be
FIGURE 3 | Increases in blood bicarbonate from baseline following acute
supplementation with calcium or sodium lactate, in order of magnitude of
change. Data points indicate whether exercise performance was improved
with supplementation (dark circles) or not (light circles). The dotted lines
indicate the thresholds for the zone of a potential ergogenic effect (+5
mmol·L−1) and the zone of an almost certain ergogenic effect (+6 mmol·L−1);
taken from Carr et al. (2) and Jones et al. (19). *Denotes data estimated from
graphs using specialized software (26, 68, 70, 72).
drawn from these independent investigations is that the time-
to-peak bicarbonate concentration differs drastically between
individuals, as does the absolute maximal change. Jones et al. (19)
showed that peak bicarbonate concentration occurred between
30 and 150, 40 and 165, and 75 and 180min following 0.1,
0.2, and 0.3 g·kg−1 BM of SB. Another study showed one
individual who peaked only 10min following supplementation
of 0.3 g·kg−1 BM of SB (76). Absolute maximal changes
in bicarbonate following SB ingestion varies greatly between
individuals (Table 1), which could be a contributing factor to
why some individuals respond more than others. Urwin et al.
(75) showed that peak bicarbonate occurred much later than the
commonly employed time given for supplementation with SC;
indeed, it has recently been suggested that this may be a key
factor contributing to the unclear effect shown with SC (77).
Thus, if the greatest likelihood of an ergogenic effect occurs at
the moment of peak circulating bicarbonate, then it is of great
importance to determine individual time-to-peak bicarbonate
following supplementation.
Determination of the time-to-peak bicarbonate concentration
is only worthwhile for repeat ingestion if subsequent blood
responses are reproducible. The consistency in blood responses
following supplementation with extracellular buffers has only
been determined with SB. Although both blood pH and
bicarbonate responses showed good reliability following repeated
supplementation with both 0.2 and 0.3 g·kg−1 BM doses of SB,
blood bicarbonate responses were more reproducible, suggesting
any individualized ingestion strategy should be based upon
the time-to-peak bicarbonate (73). Nonetheless, although no
statistical differences were shown in the time-to-peak, or the
absolute maximal changes, it currently remains unclear whether
minor changes in circulating bicarbonate significantly influence
changes in exercise performance.
Two studies have investigated the effect of peak circulating
bicarbonate concentration on exercise performance, both
following SB supplementation. Overall repeated sprint
performance was significantly improved with 0.3 g·kg−1
BM of SB compared to placebo and control (76). More recently
it has been shown that 4-km cycling time-trial performance
could be improved following both 0.2 and 0.3 g·kg−1 BM of
SB when individualized to the time-to-peak blood bicarbonate
TABLE 1 | Minimum (Min), maximum (Max), and mean time-to-peak and absolute
maximal increases in blood bicarbonate concentration following supplementation
with 0.1, 0.2, and 0.3 g·kg−1 BM sodium bicarbonate (SB) in Jones et al. (19).
Dose Blood bicarbonate
SB Time-to-peak Absolute change
(g·kg−1 BM) (min) (mmol·L−1)
Min Max Mean Min Max Mean
0.1 30 150 78 ± 34*1 +2.0 +5.0 +3.6 ± 0.8*
0.2 40 165 98 ± 32* +5.1 +8.1 +6.1 ± 0.9*
0.3 75 180 123 ± 36 +6.0 +12.3 +8.2 ± 1.4
*P < 0.05 from 0.3 g·kg−1BM; 1P < 0.05 from 0.2 g·kg−1 BM.
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(48). These findings are interesting considering two previous
investigations showed no effect of SB supplementation on
4-km time-trial performance following a 0.3 g·kg−1 BM dose.
Discrepancies could be due to timing and subsequent increases
in circulating bicarbonate. Mean bicarbonate increases in Gough
et al. (48) were +6.5 ± 1.3 mmol·L−1, which is higher than
the approximate +3 mmol·L−1 (78) and +5 mmol·L−1 (79)
shown 150 and 100min following supplement ingestion in the
other studies. Despite these initial positive results, no data exist
directly comparing exercise performed at the moment of peak
circulating bicarbonate to a standardized time (e.g., 60min)
following supplementation in the same participants. As it stands,
it cannot currently be concluded that exercise performed at peak
bicarbonate concentrations elicits greater exercise improvements
than normally seen with standardized ingestion prior to exercise.
Interestingly, recent data with SB show that determining time-
to-peak blood bicarbonate concentration may allow a lower dose
to be employed since maximal increases with 0.2 g·kg−1 BM
were similar to those seen with 0.3 g·kg−1 BM, while 4-km time-
trial performance was not different between these two doses
(80). The absolute difference in maximal bicarbonate increases
between these doses was ∼1 mmol·L−1, suggesting that such
a difference may not be meaningful. Since peak bicarbonate is
only assessed by the absolute maximal value, and not via some
statistical inference, it is possible that minor fluctuations in the
actual bicarbonate concentration following large increases may
not significantly influence subsequent exercise further, although
work remains to be done to determine the smallest worthwhile
change in blood bicarbonate that would influence exercise
performance.
Exercise Task
An increase in buffering capacity via increases in circulating
bicarbonate can lead to improvements in exercise capacity and
performance, and the magnitude of this increase in buffering
capacity appears to influence the likelihood of an effect,
although even following substantial increases not all research
is unanimous. These equivocal findings may also be due to
the exercise protocols employed. If improvements are to be
gained from increases in buffering capacity, exercise must be
limited by increases in H+ accumulation. Certainly, it has been
suggested that short-duration exercise (in this case a 30 s cycle
sprint) is unaffected by changes in muscle pH (81), while more
endurance based activities rely increasingly on aerobic energy
sources with no further increases in muscle acidosis. Therefore,
improvements following supplementation with SB, SC, and CL
and SL, are likely confined to specific exercise tasks which
are significantly influenced by changes in acid-base balance. In
fact, beta-alanine supplementation, which increases intracellular
buffering capacity via increased muscle carnosine content, has
been shown to be most effective during high-intensity exercise
of 30 s to 10min in duration, while longer and shorter duration
exercise was unaffected (82). Since the mechanism of action
of increased circulating bicarbonate is like that of beta-alanine
supplementation (i.e., increased buffering capacity), comparable
results would be expected.
Indeed, research appears to suggest exactly this. Despite
similar increases in circulating bicarbonate following a 0.3
g·kg−1 BM dose of SB, exercise lasting 10 and 30 s in duration
was unaffected, while exercise 120 and 240 s in duration
was significantly improved (83). Identical results were shown
following supplementation with 0.5 g·kg−1 BM of SC (63).
Although some evidence suggests that buffering agents may be
of benefit to longer duration exercise (36, 84), most studies
report no improvements in continuous endurance exercise
following supplementation (26, 57, 58, 85, 86). Multiple-bout
high-intensity exercise, which has been shown to result in greater
muscle acidosis than continuous supra-maximal exercise (87,
88), appears particularly susceptible to improvements with these
supplements (21, 28–30, 38, 76, 89). Interestingly, Higgins et al.
(34) showed that SB improved exercise capacity at 100% peak
mean minute power, but not at 110 or 120%, despite the duration
of all these exercise tasks being within the timeframe where an
effect may be most likely expected (82).
Taken collectively, these results suggest that the likelihood
of gaining a competitive edge from increased bicarbonate may
be, in part, dependent on the exercise performed; the duration
and intensity of the exercise appear to be key factors in this.
Thus, the exercise task performed will be a determining factor
in whether supplementation will be beneficial and cannot be
overlooked; exercise gains with these substances should only be
expected during exercise limited by the accumulation of H+.
Individuals should base their decision to supplement on their
own exercise demands and the likelihood of gaining a worthwhile
improvement therein. These are likely to be continuous high-
intensity exercise tasks, such as 4 km cycling, 100 and 200m
swimming, and 2,000m rowing, or repeated high-intensity
activities such as those performed during team sports (e.g.,
football, hockey, basketball, etc).
Hydrogen Ion Transporters
The H+ that accumulate in muscle throughout high-intensity
exercise are predominantly removed by MCT1 and MCT4,
through co-transport with lactate in a 1:1 ratio (11, 90). The
sodium/hydrogen transport system (NHE) may also contribute
to this process (91), although its relative contribution during
exercise has been suggested to be minimal (90, 92). It is widely
acknowledged that increased blood bicarbonate increases the
activity of these MCT transporters, increasing the eﬄux of H+
out of themuscle and reducingmuscle acidosis (93). Surprisingly,
no study to date has directly measured the effect of increased
circulating bicarbonate via supplementation on the activity of
these transporters in humans. It is currently unclear whether the
relationship between the increased bicarbonate and the activity
of these transporters is intrinsically associated.
Lactate transport has been shown to be elevated in athletes
(94). This makes sense since training interventions have
been shown to increase the abundance and activity of MCT
transporters (95, 96). Furthermore, lactate transport capacity
(and subsequently H+ transport) was related to the occurrence
of type I muscle fibers (97). MCT1 and MCT4 are both expressed
in human skeletal muscle, although MCT1 is more prevalent in
type I fibers andMCT4 in type II fibers (98). The higher affinity of
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MCT4 (Km = 28–34mM) compared to MCT1 (Km = 4–6mM)
for lactate, in addition to its higher prevalence in glycolytic fibers,
suggests that MCT4 may be more important for eﬄux out of
the working muscle (99). Hence, it could be suggested that any
differences in training status or muscle fiber type predominance
(i.e., trained sprinters vs. untrained individuals) may modify
the response to supplementation with extracellular buffering
agents. Indeed, this could, in part, explain some of the variation
in responses between trained and non-trained individuals; a
meta-analysis showed that the effect of SB supplementation on
exercise was significantly lower for specifically trained compared
to recreationally trained individuals (16). However, the exact
mechanisms for this reduced effect has not been investigated
and thus, suggestion that this may be due to differences in MCT
transporter activity is currently highly speculative and warrants
further investigation.
Polymorphisms in the MCT transporters may also influence
an individual’s response to supplementation. A single-nucleotide
polymorphism in the gene coding for MCT1, for example, can
influence the lactate/H+ co-transport across the sarcolemma
(100). The T allele carriers have been shown to have a
reduced MCT1 lactate transport (101, 102), TT homozygotes
reach the ventilatory threshold at higher speeds (103), while T
allele frequency has been shown to differ between athletes of
different modalities (100, 104). Despite this, the effect of this
polymorphism on high-intensity exercise performance, with or
without supplementation, is currently unclear. Although genetic
variations of the MCT4 gene exist (105), to our knowledge,
no study has investigated the relevance of any polymorphisms
on lactate/H+ flux and its effect on exercise performance. It
is apparent that polymorphisms in the genes encoding for
MCT1 and MCT4 could alter their activity during high-intensity
activity; it could thus be implied that genetic differences may
also modify the individual response to supplementation with
buffering agents, although no data currently exist. It is essential
that more research on genotypic differences in MCT transporters
and response to supplementation is undertaken before any
recommendations can be made.
Associated Side-Effects
An evident moderator of the efficacy of buffering agents to
improve exercise capacity and performance, is their associated
side-effects. The occurrence of gastrointestinal (GI) discomfort
with these supplements is common, with stomach cramps,
nausea, vomiting, and diarrhea among some of the most frequent
complaints with SB and SC (17, 75), although the only reported
side-effects with lactate supplementation was increased incidence
of belching and flatulence (72). This has obvious implications for
athletes considering supplementing during competition and is
likely a contributing factor to why incidence of supplementation
with such agents is low (106).
Following ingestion of SB, it is dissociated in the stomach
acid to form sodium (Na+) and bicarbonate, much of
the latter of which is swiftly neutralized by H+, thereby
producing carbon dioxide [CO2] (107). The production of
CO2 in the stomach may cause gastric discomfort with
symptoms including bloating and abdominal pain; nausea and
vomiting are other commonly reported side effects (17). A
contributing factor to the intensity of any side-effects with
SB is certainly dose, as McNaughton et al. (20) reported
increasing discomfort with increasing doses above 0.3 g·kg−1
BM, with no concomitant increases in performance. The
typical 0.3 g·kg−1 BM often results in reported side-effects
which may moderate performance (2, 16), although whether
they directly influence performance may be disputed. Indeed,
Price and Simons (40) reported no association between GI
discomfort and performance while data from our laboratory
has shown on several occasions that exercise capacity may be
modified by GI discomfort (18, 27). Specifically, all individuals
reporting discomfort worsened performance, and reanalyzing
data following the removal of these individuals modified the
group level statistics, turning a non-significant result into a
significant result. Thus, it is apparent that minimizing the
discomfort associated with SB supplementation could increase
the likelihood of a positive response, both at the individual
and group level. A potential solution is to ingest SB in gastro-
resistant capsules, avoiding neutralization in the stomach and the
associated side-effects; this theory is currently being tested in our
laboratory.
The timing of supplement ingestion may be a key
modifiable component that can increase or decrease the
likelihood of an ergogenic effect not only due to increased
circulating bicarbonate, but also due to the associated side-
effects. Siegler et al. (25) reported lower symptoms of GI
discomfort 180min following SB supplementation (compared
to 60 and 120min). The most intense symptoms with SC
were 60–120min following supplementation (75). Since
supplements are commonly ingested at a standardized
time, often 60min prior to the commencement of exercise
as in the case of SB, this suggests that most studies may
have forced individuals to exercise at a time when they
experience sufficient discomfort to negatively impact their
performance. Thus, adopting an individual time-to-peak
bicarbonate supplementation protocol would likely avoid
performing exercise when associated side-effects are most
intense. Although we have shown that side-effects with these
supplements could modify their ergogenic effect, it cannot
explain the lack of an effect in all individuals. Nonetheless, it is
apparent that offsetting any discomfort with supplementation
will avoid any possibility that side-effects will affect the exercise
response.
OPTIMIZING SUPPLEMENTATION
It is becoming apparent that timing of ingestion, may be
one of the key moderating factors to the ergogenic response
to increased circulating bicarbonate. Coinciding exercise with
the point at which bicarbonate peaks is likely to maximize
the chance of exercise improvements since buffering capacity
will be maximized. Importantly, early reports suggest that the
time at which peak bicarbonate occurs with SB is repeatable
within individuals (73); more information is needed regarding
consistency in blood bicarbonate responses to other buffering
agents (SC, SL, and CL). Furthermore, peak GI discomfort has
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been shown to occur earlier than maximal increases in blood
bicarbonate following SB (73, 80) and SC (75) supplementation.
Reported side-effects with lactate supplementation are minimal
and mean peak bicarbonate concentration occurred after
90min although further information is necessary regarding the
individual time course response. Altogether, data suggest that
individualizing supplementation timing with these agents may
provide the best opportunity of gaining an ergogenic effect
by coinciding the moment of exercise with peak bicarbonate
concentration following the selected dose.
FIGURE 4 | Overview of the factors which may modify the response to supplementation with sodium bicarbonate, sodium citrate, and calcium and sodium lactate.
The dose (Panel I) and timing of ingestion (Panel II) can influence both the increases in circulating bicarbonate (Panel III) and associated side-effects (Panel IV) at the
moment of exercise, impacting upon the likelihood of a performance benefit. Training status (Panel V) and genetic make-up (Panel VI) of the individual may further
modify this response. The chances of a positive response may also be modified by the duration and intensity of the exercise task being performed (Panel VII):
short-duration continuous exercise, such as 100 and 200m swimming (i) and 2,000m rowing (ii), and prolonged intermittent activity, such as football (iii), may be
particularly susceptible to improvements with these supplements.
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In fact, supplement dose is another highly modifiable factor
that could be adapted to optimize supplementation. Increasing
doses of SB above 0.3 g·kg−1 BM results in increased incidence of
GI discomfort, while 0.1 g·kg−1 BM appears insufficient to result
in exercise improvements (20). Although 0.3 g·kg−1 BM has long
been considered the optimal dose, recent evidence suggests that
0.2 g·kg−1 BMmay be equally efficient at improving performance
(80). Considering the lower incidence of GI discomfort with
similar gains in bicarbonate, a 0.2 g·kg−1 BM ingested at a
timepoint specific to the individual may be the most effective
way of maximizing the chances of an ergogenic effect with SB.
SC increased blood bicarbonate in a linear manner in doses
increasing from 0.1 to 0.5 g·kg−1 BM (54); doses above 0.5
g·kg−1 BM of SC showed no further gains in blood bicarbonate
but increased the incidence and severity of side-effects (75)
suggesting 0.5 g·kg−1 BM of SC to be the optimal dose. Lactate
supplementation results in modest increases in bicarbonate
regardless of a 0.15 or a 0.3 g·kg−1 BM dose although no
significant GI discomfort. Nonetheless, current doses of up to
0.3 g·kg−1 BM with CL or SL may be insufficient to improve
exercise though further work is necessary to ascertain whether
higher doses may be more beneficial.
PRACTICAL RECOMMENDATIONS
Individuals aiming to supplement with these substances should
trial them outside of competition to see what works for them and
adapt and optimize their individual supplementation strategies
according to their own personal needs and responses. Since
the time course response has been shown to be consistent
(at least following SB ingestion), ingestion should occur at a
time that means exercise begins when bicarbonate concentration
has increased above this +5–6 mmol·L−1 threshold. Although
there may be logistical difficulties, it would be necessary to
determine the timeframe during which individuals increase their
bicarbonate levels above +5–6 mmol·L−1, and side-effects are
minimal, so that they can adapt their supplementation timing
accordingly to optimize their chances of an effect. Individuals
should be wary that any improvements in exercise are likely to be
marginal, although this may be worthwhile for highly-trained or
elite athletes. Furthermore, the type of exercise that individuals
undertake will influence the likelihood of any benefit from
increased bicarbonate. Short-duration high-intensity exercise,
such as 4 km cycling, 2,000m rowing, and 200m swimming,
are examples of activities likely to profit from increased
buffering capacity and there is also evidence that individuals
involved in prolonged intermittent exercise may benefit from
supplementation. It appears the likelihood of obtaining an
ergogenic effect is greater when SB is ingested compared to
SC, SL, or CL, and it is the recommendation of these authors
that 0.2–0.3 g·kg−1 BM SB is taken as the preferred supplement
where possible to improve high-intensity exercise capacity and
performance limited by acidosis.
CONCLUSIONS AND FUTURE DIRECTION
Sodium bicarbonate, sodium citrate and sodium/calcium
lactate are supplements to increase circulating bicarbonate
and have all independently been shown to improve exercise
capacity and performance under various conditions. However,
several factors may modify their ergogenic effects including
supplement timing and dose, absolute changes in circulating
bicarbonate, the exercise task being performed, MCT activity,
training status, and associated side-effects (Figure 4). Emerging
evidence suggests that, to maximize the chances of an ergogenic
effect, supplementation should occur at a time point that
results in exercise being performed at the moment of peak
bicarbonate concentration, with minimal or no side-effects.
More information is required regarding each supplement
independently and their interaction with the individual,
genotype, and the environment; these have been detailed
throughout this article.
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